Bg pattern

SPECTRACEF 400 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use SPECTRACEF 400 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

SPECTRACEF 400 mg film-coated tablets

Cefditoren

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What SPECTRACEF 400 mg film-coated tablets are and what they are used for
  2. What you need to know before you take SPECTRACEF 400 mg film-coated tablets
  3. How to take SPECTRACEF 400 mg film-coated tablets
  4. Possible side effects
  5. Storage of SPECTRACEF 400 mg film-coated tablets
  6. Contents of the pack and other information

1. What SPECTRACEF 400 mg film-coated tablets are and what they are used for

SPECTRACEF belongs to a group of antibiotics called cephalosporins, which work by inhibiting the synthesis of the bacterial cell wall.

Antibiotics are used to treat bacterial infections and do not work for viral infections such as the flu or the common cold.

It is important that you follow the instructions regarding dosage, administration interval, and treatment duration as indicated by your doctor.

Do not store or reuse this medication. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw away medications via wastewater or trash.

SPECTRACEF is used in adult patients for the treatment of moderate community-acquired pneumonia.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take SPECTRACEF 400 mg film-coated tablets

Do not take SPECTRACEF

  • if you are allergic to antibiotics, particularly penicillin or other beta-lactam antibiotics, or to any of the other components of this medication (listed in section 6)
  • if you have a casein allergy, you should be aware that this medication contains sodium caseinate
  • if you have a condition called primary carnitine deficiency.

Warnings and precautions

Consult your doctor or pharmacist before starting to take SPECTRACEF

  • if you have any liver and/or kidney disease
  • if you are receiving anticoagulant therapy
  • if you have a history of gastrointestinal disease, particularly colitis
  • if you are receiving treatment with nephrotoxic agents such as aminoglycoside antibiotics or potent diuretics (such as furosemide), as these combinations may have undesirable effects on renal function and have been associated with ototoxicity.

Consult your doctor if you experience any of the following effects during treatment:

  • If during treatment you present any allergic reaction characterized by symptoms such as itching, redness, skin rash, swelling, or difficulty breathing.
  • If you present diarrhea while taking this medication or once treatment is finished.

As with other antibiotics, prolonged treatment with SPECTRACEF may lead to an overgrowth of non-susceptible microorganisms, which requires the interruption of treatment and the establishment of suitable therapy.

Treatment with SPECTRACEF may interfere with the results of some analytical tests, which may lead to false positives in:

  • The direct Coombs test.
  • Glucose determination in urine.

And false negatives in:

  • Glucose determination in blood or plasma.

Other medications and SPECTRACEF

Inform your doctor or pharmacist if you are taking, have recently taken, or may take any other medication.

Between the administration of antacids and SPECTRACEF, it is recommended to wait at least two hours.

The concomitant administration of SPECTRACEF with probenecid increases the amount of cefditoren in the blood.

Concomitant administration of SPECTRACEF with intravenous famotidine is not recommended because it may hinder the achievement of the necessary amount in the blood.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

SPECTRACEF is not recommended during pregnancy or breastfeeding.

Driving and using machines

SPECTRACEF may cause dizziness and drowsiness, which can interfere with your ability to drive or operate any tool or machine.

SPECTRACEF 400 mg film-coated tablets contain sodium

This medication contains 26.2 mg of sodium (main component of table salt) per tablet. This is equivalent to 1.3% of the maximum recommended daily sodium intake for an adult.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take SPECTRACEF 400 mg film-coated tablets

Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again. Remember to take your medication. Your doctor will indicate the duration of treatment with SPECTRACEF.

Swallow the tablets whole, with a sufficient amount of liquid (a glass of water) during meals.

The recommended dose of this medication and the frequency of administration is as follows:

Adults and adolescents (over 12 years)

It is recommended to take 1 tablet (400 mg of cefditoren) every 12 hours for 14 days.

Use in children

The use of SPECTRACEF has not been studied in patients under 12 years of age, so its administration is not recommended.

Elderly patients

In elderly patients, no dose adjustments are necessary except in cases of advanced hepatic and/or renal impairment.

Patients with renal insufficiency

No dose adjustment is necessary in patients with mild renal impairment. In patients with moderate renal insufficiency, do not exceed the dose of 200 mg of cefditoren (SPECTRACEF 200 mg) every 12 hours. In patients with severe renal insufficiency, a single dose of 200 mg of cefditoren (SPECTRACEF 200 mg) per day is recommended. The appropriate dose has not been determined in patients undergoing dialysis.

Patients with hepatic insufficiency

In mild or moderate hepatic insufficiency, it is not necessary to modify the treatment regimen. In cases of severe hepatic insufficiency, there is no data available to make a dose recommendation.

If you take more SPECTRACEF than you should

If you have taken more SPECTRACEF than recommended, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. It is recommended to bring the packaging and leaflet of the medication to the healthcare professional.

If you forget to take SPECTRACEF

In case you have forgotten a dose, take another as soon as possible and continue with the usual schedule. Do not take a double dose to make up for forgotten doses.

If you stop treatment with SPECTRACEF

Do not stop treatment before the duration indicated by your doctor, as there is a risk of relapse of the disease.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Side effects can occur mainly of a gastrointestinal nature.

Very common (more than 1 in 10 people):

  • diarrhea.

Common (1 to 10 in 100 people):

  • headache, nausea, abdominal pain, feeling of indigestion, and vaginal infection.

Uncommon (1 to 10 in 1,000 people):

  • fungal infection
  • anorexia
  • nervousness, dizziness, and sleep disorders
  • pharyngitis, rhinitis, and sinusitis
  • constipation, flatulence, vomiting, oral candidiasis, eructation, dry mouth, and loss of taste
  • liver function alteration
  • skin rash, itching, and urticaria
  • vaginal inflammation and vaginal discharge
  • fever, weakness, and sweating
  • alterations in blood cell count (leukopenia and thrombocytosis), liver function test disorders (elevation of ALT).

Rare (1 to 10 in 10,000 people):

  • hemolytic anemia and lymph node alteration
  • dehydration
  • dementia, depersonalization, emotional weakness, euphoria, hallucinations, and increased libido
  • memory loss, discoordination, increased muscle tone, meningitis, and tremor
  • photosensitivity, visual acuity loss, eye pain, and eyelid inflammation
  • tinnitus
  • heart rhythm alterations, heart failure, and fainting
  • low blood pressure
  • asthma
  • oral ulcers, stomatitis, hemorrhagic colitis, ulcerative colitis, gastrointestinal bleeding, hiccups, tongue inflammation and discoloration, diarrhea associated with Clostridium difficile
  • acne, hair loss, eczema, exfoliative dermatitis (cracked and scaly skin), and herpes simplex
  • muscle pain
  • urination pain, kidney inflammation, alterations in urination frequency, incontinence, and urinary tract infection
  • breast pain, menstrual disorders, and erectile dysfunction
  • body odor and chills
  • alterations in blood cell count (eosinophilia, neutropenia, thrombocytopenia), coagulation disorders (prolongation of coagulation time, decrease in thromboplastin time, platelet alteration), liver function test disorders (increase in AST, alkaline phosphatase), alterations in certain blood components (hyperglycemia, hypokalemia, bilirubinemia, elevation of LDH, hypoproteinemia, elevation of creatinine), or urine (albuminuria).

Frequency not known (cannot be estimated from the available data):

  • pneumonia
  • Stevens-Johnson syndrome (blisters and erosion of the skin and mucous membranes)
  • skin redness
  • toxic epidermal necrolysis (severe form of Stevens-Johnson syndrome followed by skin pain and peeling of the upper layer of the skin)
  • acute kidney failure
  • anaphylactic shock
  • serum sickness-like reaction (late allergic skin reaction)
  • decrease in blood cells (agranulocytosis)
  • decrease in carnitine values in the blood
  • cholestasis (the flow of bile from the liver is obstructed)
  • aplastic anemia (decrease in the number of blood cells)
  • liver damage
  • hepatitis.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of SPECTRACEF 400 mg film-coated tablets

Keep this medication out of sight and reach of children.

Store in the original packaging.

Do not store above 30°C.

Do not use SPECTRACEF after the expiration date stated on the packaging. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medication in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Contents of the pack and other information

Composition of SPECTRACEF 400 mg film-coated tablets
  • The active substance is cefditoren. Each tablet contains 400 mg of cefditoren (as cefditoren pivoxil).
    • Other components are:

core: sodium caseinate, sodium croscarmellose, mannitol E421, sodium tripolyphosphate, and magnesium stearate.

coating: opadry Y-1-7000 (hypromellose, titanium dioxide E171, macrogol 400) and carnauba wax.

printing ink Opacode S-1-20986 blue: shellac, brilliant blue lacquer, titanium dioxide E171, propylene glycol, and concentrated ammonia solution.

Appearance of the product and contents of the pack

SPECTRACEF 400 mg is presented in the form of film-coated tablets. Each pack contains 10 tablets. Other presentations:

SPECTRACEF 200 mg film-coated tablets: pack with 16 or 20 tablets.

Marketing authorization holder and manufacturer:

Meiji Pharma Spain, S.A.

Avda. de Madrid, 94.

28802 Alcalá de Henares, Madrid (Spain)

Date of the last revision of this leaflet:November 2020.

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Online doctors for SPECTRACEF 400 mg FILM-COATED TABLETS

Discuss questions about SPECTRACEF 400 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for SPECTRACEF 400 mg FILM-COATED TABLETS?
SPECTRACEF 400 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in SPECTRACEF 400 mg FILM-COATED TABLETS?
The active ingredient in SPECTRACEF 400 mg FILM-COATED TABLETS is cefditoren. This information helps identify medicines with the same composition but different brand names.
How much does SPECTRACEF 400 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for SPECTRACEF 400 mg FILM-COATED TABLETS is around 40.01 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures SPECTRACEF 400 mg FILM-COATED TABLETS?
SPECTRACEF 400 mg FILM-COATED TABLETS is manufactured by Meiji Pharma Spain S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of SPECTRACEF 400 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether SPECTRACEF 400 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to SPECTRACEF 400 mg FILM-COATED TABLETS?
Other medicines with the same active substance (cefditoren) include MEIACT 200 mg FILM-COATED TABLETS, MEIACT 400 mg FILM-COATED TABLETS, SPECTRACEF 200 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media